A 360° Strategy for Regulatory, Clinical, and Commercial Success
Even world-class IVD programs stall when decisions around regulatory, clinical, and technical strategy are made in silos. This whitepaper distills DCN Dx’s experience across hundreds of global submissions to identify the five most preventable—and costly—sources of delay. Packed with real-world examples and actionable frameworks, it’s a must-read for diagnostics leaders, regulatory teams, and clinical program managers looking to de-risk development and get to market with confidence.
What You’ll Learn:
- How vague or shifting intended use definitions trigger downstream submission problems
- Why skipping the FDA pre-submission pathway can cost you months
- What misaligned clinical protocols look like—and how to fix them early
- How and when to integrate human factors and usability to avoid rework
- The hidden role of data management and biostats in regulatory credibility
